US Congress calls on Novo Nordisk to lower drug prices

The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after coming under pressure from Congress.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup